| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 361.0K | $3.10M | - | |
| CFO | 152.0K | $1.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 24, 2024 | Ekaterina Malievskaia81 | 10% Owner | Sell | 1,553,130 | $0.00 | - | -33.0% | -42.0% | -2.3% | |
| Oct 24, 2024 | George Jay Goldsmith81 | 10% Owner | Sell | 1,553,130 | $0.00 | - | -33.0% | -42.0% | -2.3% | |
| Sep 26, 2024 | Atai Life Sciences N.V. | 10% Owner | Sell | 2,660,000 | $6.05 | $16,093,000.00 | -27.8% | - | - | |
| May 21, 2024 | George Jay Goldsmith81 | 10% Owner | Sell10b5-1 | 31,207 | $7.90 | $246,566.88 | -0.8% | -10.4% | -44.9% | |
| May 21, 2024 | Ekaterina Malievskaia81 | 10% Owner | Sell10b5-1 | 31,207 | $7.90 | $246,566.88 | -0.8% | -10.4% | -44.9% | |
| May 3, 2024 | George Jay Goldsmith81 | 10% Owner | Sell10b5-1 | 56,766 | $8.64 | $490,432.40 | -1.4% | -19.3% | -50.9% | |
| May 3, 2024 | Ekaterina Malievskaia81 | 10% Owner | Sell10b5-1 | 56,766 | $8.64 | $490,432.40 | -1.4% | -19.3% | -50.9% | |
| Apr 17, 2024 | George Jay Goldsmith81 | 10% Owner | Sell10b5-1 | 69,461 | $8.61 | $597,963.76 | -1.7% | -10.1% | -63.3% | |
| Apr 17, 2024 | Ekaterina Malievskaia81 | 10% Owner | Sell10b5-1 | 69,461 | $8.61 | $597,963.76 | -1.7% | -10.1% | -63.3% | |
| Apr 1, 2024 | George Jay Goldsmith81 | 10% Owner | Sell10b5-1 | 51,500 | $8.96 | $461,331.85 | -1.3% | -38.5% | -71.2% |